explore -WSS

explore

author：focus 2025-09-30 14:57:58 - browse：6

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： Sports medicine is finally prioritizing gender equality
Next article： What's changing in Medicare's open enrollment this year?

hotspot

WSS

European regulators recommend Amylyx's ALS drug be rejected

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

There’s no way to know how good AI health technologies are

What to know about a major upcoming Wegovy heart health study

North Korean leader's powerful sister says warplanes repelled US spy plane

Eight reasons why you should get an updated Covid vaccine

knowledge

explore

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Humana CEO Bruce Broussard to step down in 2024

Medical records are filled with copy

European regulators consider appeal over Amylyx ALS drug

Drug repurposing or repositioning? The language matters

How corporate America is slashing DEI workers amid backlash to diversity programs

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Sports medicine is finally prioritizing gender equality

Akero's treatment for NASH falls short in cirrhosis study

hotspot

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

European regulators consider appeal over Amylyx ALS drug

Akero's treatment for NASH falls short in cirrhosis study

Akero's treatment for NASH falls short in cirrhosis study

Trump seeks lengthy delay of classified docs trial, citing upcoming election

hotspot

knowledge

focus

knowledge